| Name | Title | Contact Details |
|---|
New Mexico Medical Review Association is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Intellivisit Solutions is a healthcare technology and modern urgent care consulting company. Our technology, Intellivisit, is a real-time artificial intelligence decision support tool specifically designed by our experts to enhance urgent care teams. Our consulting, UCP Merchant Medicine, is a full-service, turn-key consulting firm focused on improving strategic, financial, and operational outcomes with our modern urgent care model.
Lyniate offers industry-leading interoperability solutions that deliver simple and seamless integration of all health data. With two Best-in-KLAS products, Lyniate Corepoint and Lyniate Rhapsody, we established a proven reputation on which we continue to build adaptable interoperability solutions that connect the healthcare ecosystem to unlock the full potential of data. We partner with providers, health plans, and health tech solutions around the world to enable rapid, reliable, and scalable interoperability, both vertically and horizontally, on-premises and in the cloud.
Resolution Health Strategies is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.